QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 191 filers reported holding QIAGEN NV in Q4 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $51,000 | +2.0% | 1,836 | 0.0% | 0.00% | – |
| Q3 2016 | $50,000 | +25.0% | 1,836 | 0.0% | 0.00% | – |
| Q2 2016 | $40,000 | -60.8% | 1,836 | -59.9% | 0.00% | -100.0% |
| Q1 2016 | $102,000 | -19.7% | 4,581 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $127,000 | +7.6% | 4,581 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $118,000 | +3.5% | 4,581 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $114,000 | -19.1% | 4,581 | -23.7% | 0.00% | -50.0% |
| Q1 2015 | $141,000 | +20.5% | 6,005 | 0.0% | 0.00% | +100.0% |
| Q4 2014 | $117,000 | -61.9% | 6,005 | -55.5% | 0.00% | -87.5% |
| Q3 2014 | $307,000 | +11.6% | 13,485 | +19.7% | 0.01% | +14.3% |
| Q2 2014 | $275,000 | +39.6% | 11,261 | -12.8% | 0.01% | +16.7% |
| Q1 2014 | $197,000 | -10.5% | 12,908 | 0.0% | 0.01% | -25.0% |
| Q4 2013 | $220,000 | -20.9% | 12,908 | -26.2% | 0.01% | -33.3% |
| Q3 2013 | $278,000 | -59.3% | 17,479 | -49.1% | 0.01% | -50.0% |
| Q2 2013 | $683,000 | – | 34,341 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
| Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
| Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
| Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
| Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
| Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
| CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
| Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
| PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |